Aquestive Therapeutics, Inc. (AQST)
4.795
+0.14
(+2.90%)
USD |
NASDAQ |
Aug 24, 16:00
4.71
-0.08
(-1.77%)
After-Hours: 20:00
Aquestive Therapeutics Total Liabilities (Quarterly) : 188.69M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 188.69M |
| March 31, 2026 | 175.18M |
| December 31, 2025 | 195.83M |
| September 30, 2025 | 167.67M |
| June 30, 2025 | 166.29M |
| March 31, 2025 | 163.16M |
| December 31, 2024 | 161.58M |
| September 30, 2024 | 155.38M |
| June 30, 2024 | 153.08M |
| March 31, 2024 | 165.82M |
| December 31, 2023 | 163.90M |
| September 30, 2023 | 162.38M |
| June 30, 2023 | 163.64M |
| March 31, 2023 | 170.52M |
| December 31, 2022 | 175.62M |
| September 30, 2022 | 159.66M |
| June 30, 2022 | 152.67M |
| March 31, 2022 | 149.67M |
| Date | Value |
|---|---|
| December 31, 2021 | 144.13M |
| September 30, 2021 | 125.64M |
| June 30, 2021 | 120.64M |
| March 31, 2021 | 113.72M |
| December 31, 2020 | 111.38M |
| September 30, 2020 | 86.94M |
| June 30, 2020 | 84.93M |
| March 31, 2020 | 85.32M |
| December 31, 2019 | 84.60M |
| September 30, 2019 | 83.28M |
| June 30, 2019 | 75.06M |
| March 31, 2019 | 74.04M |
| December 31, 2018 | 76.77M |
| September 30, 2018 | 66.57M |
| June 30, 2018 | 78.79M |
| March 31, 2018 | 68.48M |
| December 31, 2017 | 69.61M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| LENZ Therapeutics, Inc. | 17.33M |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 132.10M |
| Shareholders Equity (Quarterly) | -56.59M |
| Debt to Equity Ratio | -2.635 |
| Current Ratio | 7.191 |
| Net Debt Paydown Yield | -0.94% |